Observational studyAnnals of surgical oncology2026
Surgical Safety after Preoperative Chemotherapy for Perihilar Cholangiocarcinoma: Multi-Institutional Propensity-Matched Analysis.
Observational study in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPerihilar cholangiocarcinoma (PHCC) presents a significant clinical challenge, often necessitating extensive hepatectomy in conjunction with extrahepatic bile duct resection (Hx + EBDR). The impact of preoperative chemotherapy on surgical outcomes remains uncertain. This multicenter retrospective cohort study aimed to assess the surgical and survival outcomes of patients with PHCC who received chemotherapy.
methodsWe conducted a retrospective analysis of 563 patients who underwent extensive hepatectomy with extrahepatic bile duct resection for PHCC, including 81 patients who received preoperative chemotherapy. Propensity score matching was utilized to compare perioperative, pathological, and long-term outcomes between the two groups.
resultsThe morbidity and mortality rates in the chemotherapy group were 52% and 4%, respectively. The main postoperative complications were organ/space surgical site infection (27%), bile leakage (26%), and postoperative liver failure (21%), including duplicating occurrences, respectively. Following propensity score matching (n=80 per group), no significant differences were observed in operative time, intraoperative blood loss, morbidity, mortality, or pathological findings, including R0 resection rates. Across the entire cohort, the 5-year overall survival rates were 32.7% for the chemotherapy group and 30.9% for the control group (p=0.982).
conclusionsPreoperative chemotherapy for PHCC is associated with comparable surgical morbidity and mortality, despite longer operative times. Propensity score-matched analysis indicates that preoperative chemotherapy does not negatively affect surgical or pathological outcomes.
Indexed as
Identifiers
42412354What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.